BEXSERO
Biological
GlaxoSmithKline, LLC.
Total Payments
$11.8M
Transactions
142,595
Doctors
48,121
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2024 | $588,903 | 13,646 | 9,154 |
| 2023 | $1.6M | 19,509 | 11,201 |
| 2022 | $1.4M | 18,190 | 11,426 |
| 2021 | $986,218 | 16,971 | 10,640 |
| 2020 | $2.9M | 12,393 | 7,564 |
| 2019 | $3.5M | 27,928 | 16,770 |
| 2018 | $479,614 | 20,618 | 13,359 |
| 2017 | $331,299 | 13,340 | 9,611 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $5.5M | 1,738 | 46.6% |
| Food and Beverage | $3.2M | 138,194 | 27.4% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $2.5M | 1,083 | 20.9% |
| Travel and Lodging | $418,404 | 1,447 | 3.6% |
| Consulting Fee | $147,742 | 39 | 1.3% |
| Space rental or facility fees (teaching hospital only) | $40,300 | 25 | 0.3% |
| Education | $503.85 | 69 | 0.0% |
Payments by Type
General
$6.3M
140,857 transactions
Research
$5.5M
1,738 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| MENB REC 2ND GEN-023 (V72_57) | GlaxoSmithKline, LLC. | $5.5M | 0 |
| MENB REC 2ND GEN (V72_92) | GlaxoSmithKline, LLC. | $8,473 | 0 |
Top Doctors Receiving Payments for BEXSERO — Page 2
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| , M.D | Pediatrics | Syracuse, UT | $7,695 | 18 |
| , MD | Pediatric Infectious Diseases | Madison, WI | $7,127 | 9 |
| , MD | Obstetrics & Gynecology | Boise, ID | $6,652 | 1 |
| , MD/PHD | Pediatric Infectious Diseases | Shreveport, LA | $6,399 | 1 |
| , MD | Pediatrics | South Jordan, UT | $6,141 | 5 |
| , MD, MPH | Maternal & Fetal Medicine | Lake Forest, IL | $5,902 | 1 |
| , MD | Addiction Psychiatry | Charleston, SC | $4,827 | 8 |
| , MD | Adolescent Medicine | Hagerstown, MD | $4,705 | 9 |
| , M.D | Internal Medicine | New Haven, CT | $4,634 | 5 |
| , M.D | Pediatrics | Charleston, SC | $4,427 | 12 |
| , MD | Pediatrics | Englewood, NJ | $4,371 | 23 |
| , APRN,BC | Family | Murray, UT | $4,301 | 3 |
| , MD | Family Medicine | Bountiful, UT | $4,275 | 5 |
| , MD | Pediatrics | Farmington, UT | $4,183 | 10 |
| , M.D | Pediatrics | Darien, CT | $4,068 | 10 |
| , M.D | Pediatrics | Pomona, NY | $4,052 | 19 |
| , MD | Pediatrics | Ridgewood, NJ | $4,001 | 4 |
| , MD | Family Medicine | Lewisburg, PA | $3,782 | 4 |
| , MD | Pediatrics | Dublin, OH | $3,570 | 11 |
| , DO | Family Medicine | Center Point, IA | $3,171 | 4 |
| Melvin Russell | — | Tallassee, AL | $2,795 | 1 |
| , DO | Pediatrics | East Meadow, NY | $2,696 | 1 |
| , D.O | Internal Medicine | Santa Fe Springs, CA | $2,400 | 2 |
| , MD | Pediatrics | Dallas, TX | $2,291 | 14 |
| , MD | Specialist | Omaha, NE | $2,068 | 5 |
Ad
Manufacturing Companies
- GlaxoSmithKline, LLC. $11.8M
Product Information
- Type Biological
- Total Payments $11.8M
- Total Doctors 48,121
- Transactions 142,595
About BEXSERO
BEXSERO is a biological associated with $11.8M in payments to 48,121 healthcare providers, recorded across 142,595 transactions in the CMS Open Payments database. The primary manufacturer is GlaxoSmithKline, LLC..
Payment data is available from 2017 to 2024. In 2024, $588,903 was paid across 13,646 transactions to 9,154 doctors.
The most common payment nature for BEXSERO is "Unspecified" ($5.5M, 46.6% of total).
BEXSERO is associated with 2 research studies, including "MENB REC 2ND GEN-023 (V72_57)" ($5.5M).